Literature DB >> 19924151

Diabetes: diabetes therapy and cancer risk.

Riccardo Vigneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19924151     DOI： 10.1038/nrendo.2009.219

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Obesity and cancer.

Authors:  P Vigneri; F Frasca; L Sciacca; L Frittitta; R Vigneri
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-01       Impact factor: 4.222

2.  Insulin analogues with increased mitogenic potency--are they safe?

Authors:  B F Hansen
Journal:  Horm Metab Res       Date:  2008-04-16       Impact factor: 2.936

3.  Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

Authors:  P Kurtzhals; L Schäffer; A Sørensen; C Kristensen; I Jonassen; C Schmid; T Trüb
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

4.  New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.

Authors:  Gillian Libby; Louise A Donnelly; Peter T Donnan; Dario R Alessi; Andrew D Morris; Josie M M Evans
Journal:  Diabetes Care       Date:  2009-06-29       Impact factor: 19.112

5.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.

Authors:  L G Hemkens; U Grouven; R Bender; C Günster; S Gutschmidt; G W Selke; P T Sawicki
Journal:  Diabetologia       Date:  2009-06-30       Impact factor: 10.122

Review 6.  Diabetes and cancer.

Authors:  Paolo Vigneri; Francesco Frasca; Laura Sciacca; Giuseppe Pandini; Riccardo Vigneri
Journal:  Endocr Relat Cancer       Date:  2009-07-20       Impact factor: 5.678

7.  The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Authors:  C J Currie; C D Poole; E A M Gale
Journal:  Diabetologia       Date:  2009-07-02       Impact factor: 10.122

8.  Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.

Authors:  J M Jonasson; R Ljung; M Talbäck; B Haglund; S Gudbjörnsdòttir; G Steineck
Journal:  Diabetologia       Date:  2009-07-09       Impact factor: 10.122

9.  Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Authors:  H M Colhoun
Journal:  Diabetologia       Date:  2009-07-15       Impact factor: 10.122

10.  Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152
  10 in total
  18 in total

1.  Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

Authors:  Todd MacKenzie; Michael S Zens; Assiamira Ferrara; Alan Schned; Margaret R Karagas
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.

Authors:  Yanqiao Zhang; Xuemei Ge; Lydia A Heemstra; Wei-Dong Chen; Jiesi Xu; Joseph L Smith; Huiyan Ma; Neda Kasim; Peter A Edwards; Colleen M Novak
Journal:  Mol Endocrinol       Date:  2012-01-19

3.  Angiogenesis and inflammation at the crossroads between diabetes and cancer: PS226.

Authors:  R Rocha; I Rodrigues; I Gullo; G Gonçalves; J Pedro; D Carvalho; F Carneiro; R Soares; S Andrade
Journal:  Porto Biomed J       Date:  2017-09-01

4.  Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article.

Authors:  Mohammed T Qaoud; Ihab Almasri; Tijen Önkol
Journal:  Turk J Pharm Sci       Date:  2022-06-27

Review 5.  Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.

Authors:  Hong Fang; Baodong Yao; Yujie Yan; Huilin Xu; Yinan Liu; Hongmei Tang; Jie Zhou; Lili Cao; Weijie Wang; Jinling Zhang; Liyun Zhao; Xi Chen; Fen Zhang; Yanping Zhao
Journal:  Diabetes Technol Ther       Date:  2013-11       Impact factor: 6.118

6.  Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.

Authors:  Zhaowei Zhu; Xiaohua Zhang; Zhoujun Shen; Shan Zhong; Xianjin Wang; Yingli Lu; Chen Xu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 7.  Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies.

Authors:  Lang Wu; Jingjing Zhu; Larry J Prokop; Mohammad Hassan Murad
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

Review 8.  Cancer biology in diabetes.

Authors:  Shi Sen; Yanzheng He; Daisuke Koya; Keizo Kanasaki
Journal:  J Diabetes Investig       Date:  2014-03-05       Impact factor: 4.232

9.  Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells.

Authors:  Frederico Alisson-Silva; Leonardo Freire-de-Lima; Joana L Donadio; Miguel C Lucena; Luciana Penha; Julliana N Sá-Diniz; Wagner B Dias; Adriane R Todeschini
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations.

Authors:  Fang Hua; Ke Li; Jiao-Jiao Yu; Xiao-Xi Lv; Jun Yan; Xiao-Wei Zhang; Wei Sun; Heng Lin; Shuang Shang; Feng Wang; Bing Cui; Rong Mu; Bo Huang; Jian-Dong Jiang; Zhuo-Wei Hu
Journal:  Nat Commun       Date:  2015-08-13       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.